EBO Share Price Performance
NZ$24.08
-14.93 (-38.27%)
31.6% undervalued intrinsic discount
NZ$35.22
Fair Value
Price NZ$24.08
AnalystConsensusTarget NZ$35.22
AnalystHighTarget NZ$41.16
AnalystLowTarget NZ$23.77
Fair ValueNZ$35.22
Share Pricen/a
EBOS Group Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 49 Fair Values set on narratives written by author
EBO Community Narratives
AN
Fair Value NZ$35.22 31.6% undervalued intrinsic discount
Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains
0users have liked this narrative
0users have commented on this narrative
27users have followed this narrative
AN
Fair Value NZ$41.16 41.5% undervalued intrinsic discount
Ageing Populations And New Distribution Centers Will Support Long Term Healthcare And Animal Care Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value NZ$23.77 1.3% overvalued intrinsic discount
Future Mix Shift Toward High Value Medicines Will Pressure Margins And Earnings
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains
Key Takeaways Logistics upgrades and automation will reduce costs and improve margins, with benefits accelerating as capital spending returns to normal. Demographic shifts and specialty pharma expansion are driving long-term, diversified revenue growth and enhancing operational resilience.Read more
422
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
27users have followed this narrative
AN
NZ$35.22
31.6% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
5.63% p.a.
Profit Margin
2.15%
Future PE
23.97x
Price in 2029
NZ$43.43
Ageing Populations And New Distribution Centers Will Support Long Term Healthcare And Animal Care Demand
Catalysts About EBOS Group EBOS Group is a diversified healthcare and animal care distributor and brand owner operating across Australia, New Zealand and Southeast Asia. What are the underlying business or industry changes driving this perspective?Read more
16
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
NZ$41.16
41.5% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
8.32% p.a.
Profit Margin
2.46%
Future PE
26.28x
Price in 2029
NZ$57.52
Future Mix Shift Toward High Value Medicines Will Pressure Margins And Earnings
Catalysts About EBOS Group EBOS Group is a diversified healthcare and animal care company operating across pharmacy wholesale, institutional healthcare, medical technology, contract logistics and branded pet products in Australia, New Zealand and Southeast Asia. What are the underlying business or industry changes driving this perspective?Read more
70
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
NZ$23.77
1.3% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
5.33% p.a.
Profit Margin
1.97%
Future PE
20.61x
Price in 2029
NZ$33.22
Trending Discussion
Recently Updated Narratives
AN
EBO: Lower Forward P/E Reset Will Support Future Capital Efficiency Reassessment
Fair Value: NZ$35.22 31.6% undervalued intrinsic discount
27 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Ageing Populations And New Distribution Centers Will Support Long Term Healthcare And Animal Care Demand
Fair Value: NZ$41.16 41.5% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Future Mix Shift Toward High Value Medicines Will Pressure Margins And Earnings
Fair Value: NZ$23.77 1.3% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
EBOS Group Limited Key Details
About EBO
- Founded
- 1922
- Employees
- 5770
- CEO
- WebsiteView website
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
